Elan 2011          Elan 2011
Annual Report      Form 20-F

Webcast Replay: Elan Reports First Quarter 2012 Financial Results

Alzheimer’s Disease

• ELND005, Phase II Studies. More.  

Crohn’s Disease

• TYSABRI INFORM Study. More.

BioNeurology
products and pipeline.
View.

05/17/2012: New Analysis of Risk Stratification for TYSABRI® Published in New England Journal of Medicine More.

04/27/2012: Elan to Present at Deutsche Bank 37th Annual Healthcare Conference More.

04/26/2012: New TYSABRI Data Presented at 64th Annual AAN Meeting Highlight Biogen Idec & Elan Commitment to Improving... More.